{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T06:48:52Z","timestamp":1720680532200},"reference-count":8,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jcin.2014.11.008","type":"journal-article","created":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T21:45:30Z","timestamp":1421790330000},"page":"221-222","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"PB","title":["Heparin May Be Hard to Beat"],"prefix":"10.1016","volume":"8","author":[{"given":"Rod H.","family":"Stables","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2014.11.008_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(14)61216-2","article-title":"Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials","volume":"384","author":"Cavender","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2014.11.008_bib2","article-title":"Bivalirudin versus heparin in\u00a0patients treated with percutaneous coronary intervention: a meta-analysis of randomised trials","author":"Cassese","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2014.11.008_bib3","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2014.11.008_bib4","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(14)60924-7","article-title":"Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial","volume":"384","author":"Shahzad","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2014.11.008_bib5","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1311096","article-title":"Bivalirudin started during emergency transport for primary PCI","volume":"369","author":"Steg","year":"2013","journal-title":"N\u00a0Engl J\u00a0Med"},{"key":"10.1016\/j.jcin.2014.11.008_bib6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jcin.2014.11.002","article-title":"Acute stent thrombosis after primary percutaneous coronary interventions: insights from the EUROMAX trial (European Ambulance Acute Coronary Syndrome Angiography)","volume":"8","author":"Clemmensen","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2014.11.008_bib7","unstructured":"Wood S. Light from BRIGHT: more fuel for bivalirudin-heparin debate. Medscape. Sep 15, 2014. Available at: http:\/\/www.medscape.com\/viewarticle\/831717. Accessed November 30,\u00a02014."},{"key":"10.1016\/j.jcin.2014.11.008_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/clc.22268","article-title":"Comparison of prasugrel and bivalirudin vs clopidogrel and heparin\u00a0in patients with ST-segment elevation myocardial infarction: design and rationale of the Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4\u00a0trial","volume":"37","author":"Schulz","year":"2014","journal-title":"Clin Cardiol"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879814015969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879814015969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T05:54:13Z","timestamp":1537941253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879814015969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1936879814015969"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2014.11.008","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin May Be Hard to Beat","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2014.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2014.11.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}